S. Reuter et al., Pericystic metabolic activity in alveolar echinococcosis: Assessment and follow-up by positron emission tomography, CLIN INF D, 29(5), 1999, pp. 1157-1163
Information on parasite viability in alveolar echinococcosis (AE) cannot be
obtained by conventional imaging techniques. We evaluated the glucose meta
bolism of AE lesions by use of [F-18]fluorodeoxyglucose positron emission t
omography (FDG-PET) in 12 inoperable patients. Eight patients showed either
perilesional or focal enhancement ("hot spots"), whereas 4 patients had no
nenhancing (metabolically inactive) lesions. With PET, necrotic parasitic l
esions and areas of enhanced metabolic activity could be clearly discrimina
ted. Most notably, 3 of 8 patients with metabolically active lesions who we
re reexamined after chemotherapy treatment clearly showed improvement: the
initial surrounding hot spots had disappeared in 2 of them, and had signifi
cantly decreased in 1. PET may prove valuable in assessing the efficacy of
chemotherapy by showing the disappearance of metabolic activity and may als
o be useful for timely detection of relapses and metastases. Although costl
y and not readily available, FDG-PET is a promising tool toward improved ma
nagement of AE and may thus help lower costs of long-term chemotherapy.